Skip to content

Hand Eczema in the Health Care Sector

Hand Eczema in the Health Care Sector

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04449575
Enrollment
300
Registered
2020-06-29
Start date
2020-07-01
Completion date
2022-01-31
Last updated
2021-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Eczema

Brief summary

This project aims to investigate the prevalence of bacterial colonization and associated factors in health care workers with hand eczema with focus on Staphylococcus aureus.

Detailed description

Two groups will be examined in this study: health care workers with HE and matched controls invited through a questionnaire study which will be sent to approximately 4000 health care workers in Capital Region. Samples from health care workers with and without hand eczema will be collected after obtaining their written informed consent. Collection of samples: Swabs will be rubbed on the skin for 30 seconds on lesional and non-lesional skin on the dominating hand and from the nostrils. The swabs will immediately be stored in -80 C° (research biobank) for subsequent analysis at Statens Serum Institute.

Interventions

OTHEReSwabs

from skin

Sponsors

Statens Serum Institut
CollaboratorOTHER
University Hospital Bispebjerg and Frederiksberg
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* The diagnosis of hand eczema (for group with hand eczema)

Exclusion criteria

* Other skin diseases (in both groups)

Design outcomes

Primary

MeasureTime frameDescription
Staphyloccous aureus presenceBaseline, cross-sectionalPrevalence of S. aureus colonization on hands and in nose in two groups of health care workers. The swab samples will be assessed by culturing on selective S. aureus plates (chromID S. aureus; bioMerieux, Marcy l'Etoile, France) and incubated overnight at 37 °C. DNA will be purified from S. aureus isolates using the Qiagen DNeasy Blood and Tissue Purification Kit (Qiagen, Hilden, Germany).

Secondary

MeasureTime frameDescription
CC-types and spa-typingBaseline, cross-sectionalclonal complex (CC) type and spa-types are characterizing the S. aureus. Will be correlated to departments and professions of health care workers. The S. aureus will be further characterized by spa typing, which will be performed by polymerase chain reaction and Sanger sequencing of the product. The respective CC types will be assigned from the spa type using eBURST (http://eburst.mlst.net).
Hand Eczema Severity Index (HECSI)Baseline, cross-sectionalValidated severity measurement tool for hand eczema performed by the investigator. Severity will be correlated to S. aureus colonization and CC types

Countries

Denmark

Contacts

Primary ContactYasemin T. Yüksel, MD
yasemin.topal.yueksel@regionh.dk004522917017
Backup ContactTove Agner, MD, PhD
tove.agner@regionh.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026